Skip to main content

Day: September 2, 2025

Eisai Initiated Rolling Supplemental Biologics License Application to the U.S. FDA for LEQEMBI® IQLIK™ (lecanemab-irmb) as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer’s Disease Under Fast Track Status

LEQEMBI IQLIK, if approved for initiation dosing, would be the first and only anti-amyloid treatment to offer at-home injection from the start to help patients and care partners treat this progressive, relentless disease TOKYO and CAMBRIDGE, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) — Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) announced today that Eisai has initiated the rolling submission of the Supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) for lecanemab-irmb (U.S. brand name: LEQEMBI®) subcutaneous autoinjector (SC-AI), LEQEMBI IQLIK, as a weekly starting dose after the FDA granted Fast Track Status. LEQEMBI is indicated for the treatment...

Continue reading

Fortis Inc. Announces Pricing of Fixed-to-Fixed Rate Subordinated Notes

Not for distribution to U.S. news wire services or dissemination in the United States. This news release constitutes a “designated news release” for the purposes of the Corporation’s prospectus supplement dated December 9, 2024 to Fortis’ short form base shelf prospectus dated December 9, 2024. ST. JOHN’S, Newfoundland and Labrador, Sept. 02, 2025 (GLOBE NEWSWIRE) — Fortis Inc. (“Fortis” or the “Corporation”) (TSX: FTS) announced today that it has priced an offering by private placement (the “Offering”), pursuant to the exemptions from the prospectus requirements of applicable Canadian securities laws, of $750 million aggregate principal amount of 5.100% fixed-to-fixed rate subordinated notes due December 4, 2055 (the “Notes”). The Offering is being made...

Continue reading

Evolution Petroleum Schedules Fiscal Year End 2025 Earnings Release and Conference Call

HOUSTON, Sept. 02, 2025 (GLOBE NEWSWIRE) — Evolution Petroleum Corporation (NYSE American: EPM) (“Evolution” or the “Company”) today announced that it plans to release its fourth quarter and fiscal year-end 2025 financial and operating results on Tuesday, September 16, 2025, after the market closes. Additionally, Kelly Loyd, President and Chief Executive Officer, Ryan Stash, Senior Vice President, Chief Financial Officer, and Treasurer, and Mark Bunch, Chief Operating Officer, will review the results on a conference call at 10:00 a.m. Central Time on Wednesday, September 17, 2025. Conference Call and Webcast Details Date: Wednesday, September 17, 2025Time: 10:00 a.m. Central TimeDial-In: (844) 481-2813International Dial-In: (412) 317-0677Note: Dial-in participants should ask to join the Evolution Petroleum...

Continue reading

CEA Industries (BNC) Appoints Seasoned Global Investments Leader, Dr. Russell Read, as Non-Executive Director

New York, Sept. 02, 2025 (GLOBE NEWSWIRE) — CEA Industries Inc. (Nasdaq: BNC), (“BNC” or “the Company”), a growth-oriented company focused on managing the world’s largest corporate treasury of BNB, today announced the appointment of Dr. Russell Read, Ph.D., CFA, as a Non-Executive Director of the Company, effective immediately. Dr. Read brings more than three decades of global investment leadership and governance experience across sovereign wealth funds, pension systems, private investment firms, and financial institutions in North America, Europe, Asia, and the Middle East. Currently, Dr. Read serves as Co-Founder, Chief Investment Officer, and Director at Measa Partners, a global investment and advisory firm. He previously held senior leadership roles as Chief Investment Officer of the California Public Employees Retirement System...

Continue reading

California Water Service Increases Rebates on Water-Efficient Devices to Encourage Customers to Save Water Every Day

SAN JOSE, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) — To help encourage its customers to save more water, California Water Service (Cal Water) has increased the value of conservation rebates available for purchases of popular indoor and outdoor conservation-related products. For a limited time, customers can get increased rebates on a range of products, from high-efficiency clothes washers to low-water-use landscaping. Rebates with increased incentives include:Residential high-efficiency toilets, now up to $150 Residential high-efficiency clothes washers, now up to $500 Residential lawn-to-garden conversions, now up to $5 per square foot Commercial high-efficiency toilets, now up to $200 Commercial high-efficiency urinals, now up to $300 Commercial lawn-to-garden conversions, now up to $3 per square footRebate funds are limited...

Continue reading

Skyward Specialty Insurance Group to Acquire Apollo Group Holdings Limited, Amplifying “Rule Our Niche” Strategy

HOUSTON, Sept. 02, 2025 (GLOBE NEWSWIRE) — Skyward Specialty Insurance Group, Inc.® (Nasdaq: SKWD) (“Skyward Specialty” or the “Company”) today announced it has entered into a definitive agreement with the majority sellers to acquire 100% of Apollo Group Holdings Limited (“Apollo”) for a total consideration of $555 million from Alchemy, management, employees, and other strategic investors. Employees and strategic investors will receive $184 million of stock consideration(1), while the remaining $371 million will be paid in cash, with committed debt financing in place. The transaction is expected to deliver double-digit adjusted operating EPS(2) accretion in the first full year post closing while adding more than $1.5 billion of managed premium(3), further reinforcing Skyward Specialty’s position as a leader in U.S. specialty markets. Apollo...

Continue reading

Aimfinity Investment Corp. I Announces New Monthly Extension for Business Combination

Wilmington, DE, Sept. 02, 2025 (GLOBE NEWSWIRE) — Aimfinity Investment Corp. I (the “AIMA”) (Nasdaq: AIMTF), a special purpose acquisition company incorporated as a Cayman Islands exempted company, today announced that, in order to extend the date by which the Company mush complete its initial business combination from August 28, 2025 to September 28, 2025, on August 28, 2025, I-Fa Chang, manager of the sponsor of the Company, has deposited into its trust account (the “Trust Account”) an aggregate of $55,823.8, or for $0.05 per Class A ordinary share held by public shareholders (the “Monthly Extension Payment”). Pursuant to the Company’s fourth amended & restated memorandum and articles of association (“Current Charter”), effectively January 9, 2025, the Company may extend on a monthly basis from January 28, 2025 until October...

Continue reading

Dorchester Minerals, L.P. Announces Acquisition of Mineral Interests

DALLAS, Sept. 02, 2025 (GLOBE NEWSWIRE) — Dorchester Minerals, L.P. (the “Partnership”) (NASDAQ-DMLP) announced today it completed an acquisition of mineral interests totaling approximately 3,050 net royalty acres located in Adams County, Colorado. The transaction was structured as a non-taxable contribution and exchange. The contributing entities conveyed their interests to the Partnership in exchange for 915,694 common units representing limited partnership interests in Dorchester Minerals, L.P. Dorchester Minerals, L.P. is a Dallas based owner of producing and non-producing oil and natural gas mineral, royalty, overriding royalty, and net profits interests located in 28 states. Its common units trade on the NASDAQ Global Select Market under the symbol DMLP. FORWARD-LOOKING STATEMENTS Portions of this document may constitute...

Continue reading

Rapid Micro Biosystems to Present at the H.C. Wainwright 27th Annual Global Investment Conference

LEXINGTON, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) — Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced that the Company will present at the H.C.Wainwright 27th Annual Global Investment Conference in New York, NY. The Company is scheduled to present on Tuesday, September 9, 2025, at 11:00 a.m. ET. A live webcast of the presentation will be available on the Rapid Micro Biosystems investor relations website at https://investors.rapidmicrobio.com/ and can be accessed here. The webcast will be archived and available for replay after the event. About Rapid Micro Biosystems Rapid Micro Biosystems is an innovative life sciences technology...

Continue reading

Guggenheim Investments Announces September 2025 Closed-End Fund Distributions

NEW YORK, Sept. 02, 2025 (GLOBE NEWSWIRE) — Guggenheim Investments today announced that certain closed-end funds have declared their distributions. The table below summarizes the distribution schedule for each closed-end fund (collectively, the “Funds” and each, a “Fund”). The following dates apply to the distributions:Record DateSeptember 15, 2025Ex-Dividend DateSeptember 15, 2025Payable Date September 30, 2025 Distribution ScheduleNYSE Ticker Closed-End Fund Name Distribution Per Share Change from Previous Distribution FrequencyAVK Advent Convertible and Income Fund $0.1172†   MonthlyGBAB Guggenheim Taxable Municipal Bond & Investment Grade Debt Trust $0.12573†   MonthlyGOF Guggenheim Strategic Opportunities Fund $0.1821†   MonthlyGUG Guggenheim Active Allocation Fund $0.11875†   Monthly†...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.